Who are Collagenase Santyl Vehicle's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): DGD.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/collagenase-santyl-vehicle.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Collagenase Santyl Vehicle — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Collagenase Santyl Vehicle (Collagenase Santyl Vehicle) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Enzymatic debridement agent. Area: Wound Care / Dermatology.

marketed Enzymatic debridement agent Collagen (fibrous protein substrate) Wound Care / Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Collagenase Santyl Vehicle (Collagenase Santyl Vehicle) — Healthpoint. Collagenase enzymatically breaks down collagen in necrotic tissue, facilitating debridement of wounds.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Collagenase Santyl Vehicle TARGET	Collagenase Santyl Vehicle	Healthpoint	marketed	Enzymatic debridement agent	Collagen (fibrous protein substrate)
DGD	DGD	MediWound Ltd	phase 3	Enzymatic debridement agent	Denatured collagen and extracellular matrix proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Enzymatic debridement agent class)

Healthpoint · 1 drug in this class
MediWound Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Collagenase Santyl Vehicle — Competitive Intelligence Brief. https://druglandscape.com/ci/collagenase-santyl-vehicle. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab